Israeli drug is world's first proven to slow Parkinson's

jpost.com — Teva?s Aziltec drug was proven to be effective, safe and well tolerated in one of the largest ever studies conducted on the Parkinson?s disease. The ADAGIO study covered 1,176 patients with early Parkinson's at 129 centers in 14 countries over a period of 18 months. These results could turn Aziltec into a "disease modification" labeled drug. Jun 17, 2008 View in Crawl 4